Healthcare Gap Identified
- Patients at risk for axial spondyloarthritis (axSpA) are not being identified and referred to a specialist in a timely manner, risking delayed and/or inappropriate diagnosis and care
- Patients with suspected or confirmed axSpA are not receiving the lifestyle and/or pharmaceutical interventions that may optimize their outcomes
Audio-enhanced slide lecture
A hallmark feature of axSpA is inflammatory back pain, but it can sometimes be indistinguishable from chronic back pain of another cause. In the past decade, major progress has been made in the recognition and treatment of axSpA. With the availability of newer assessment methods and effective therapeutic agents, early diagnosis and appropriate treatment are possible. In this activity, expert faculty will discuss the clinical burden and characteristics of axSpA. Treatment options and lifestyle counseling will also be reviewed.
After completing this activity, participants should be better able to:
- Apply knowledge of the clinical features of axSpA to the identification of patients who are at risk and refer to a specialist as appropriate
- Evaluate the benefits and limitations of available and emerging lifestyle and pharmacologic interventions for patients with axSpA
Nurse practitioners (NPs) and physician assistants (PAs)
The University of Nebraska Medical Center College of Nursing Continuing Nursing Education is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
This activity is provided for 1.0 contact hour under ANCC criteria.
This activity is provided for 0.25 hours related to pharmacotherapeutic content.
The University of Nebraska Medical Center College of Nursing Continuing Nursing Education has been awarded Accreditation with Distinction, the highest recognition awarded by the American Nurses Credentialing Center's Accreditation Program. This distinction is valid through November 2020.
This program has been reviewed and is approved for a maximum of 1.00 hour(s) of AAPA Category 1 CME credit by the PA Review Panel. Approval is valid for 1 year from the issue date of February 28, 2017. Participants may submit the post-test at any time during that period.
This program was planned in accordance with AAPA's CME Standards for Enduring Material Programs and for Commercial Support of Enduring Material Programs.
This activity was supported by an educational grant from Novartis Pharmaceuticals Corporation.
The opinions or views expressed in this continuing education activity are those of the faculty and do not necessarily reflect the opinions or recommendations of the University of Nebraska Medical Center College of Nursing Continuing Nursing Education, American Academy of Physician Assistants, Continuing Education Alliance, Practicing Clinicians Exchange, Vindico Medical Education, or Novartis Pharmaceuticals Corporation.
Accredited status as a provider of continuing nursing education refers only to the University of Nebraska Medical Center College of Nursing Continuing Nursing Education continuing education activities, and does not imply UNMC or American Nurses Credentialing Center's Commission on Accreditation endorsement of any commercial supporters.
Please note that while the University of Nebraska Medical Center College of Nursing Continuing Nursing Education is an ANCC accredited organization, this does not imply endorsement by the UNMC or ANCC of any commercial products affiliated with this activity.
All faculty and planners participating in continuing education activities sponsored by the University of Nebraska Medical Center College of Nursing Continuing Nursing Education are expected to disclose to the audience any significant support or substantial relationship(s) with providers of commercial products and/or devices discussed in this activity and/or with any commercial supporters of the activity. In addition, all faculty are expected to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in this activity. The faculty and planning committee have been advised that this activity must be free from commercial bias, and based upon all the available scientifically rigorous data from research that conforms to accepted standards of experimental design, data collection, and analysis.
Please note that this activity may refer to use of products for a purpose other than which they were approved by the US Food and Drug Administration.
Dr Gensler: advisor: AbbVie, Janssen, Novartis.
Mr Pope has nothing to disclose with regard to commercial interests.
The Planning Committee for this activity included Heidi Keeler, PhD, RN, of the University of Nebraska Medical Center College of Nursing Continuing Nursing Education; Mark P. Christiansen, PhD, PA-C, of the University of the Pacific; and Ruth Cohen and Magaret Inman of Practicing Clinicians Exchange. The members of the Planning Committee have no significant relationships to disclose.
Participants wishing to earn CE/CME credit must:
- Listen to the presentation and study the program slides
- Relate the content material to the learning objectives
- Complete the post-test and evaluation form online
Successful completion of the post-test is required to earn CE/CME credit. Successful completion is defined as a cumulative score of at least 70%.
The estimated time to complete this activity is 1.00 hours.
Release date: February 28, 2017
Expiration date: February 28, 2018
© 2018 Practicing Clinicians Exchange. All Rights Reserved. NPCE90316